GENK

GEN Restaurant Group, Inc.

40
Fundamentals29/ 100
Valuation50/ 100
Upside potential61/ 100
Risk potential36/ 100

GENK offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

NKE

NIKE, Inc.

60
Fundamentals56/ 100
Valuation80/ 100
Upside potential58/ 100
Risk potential18/ 100

NKE has the edge over GENK overall, supported by stronger valuation and stronger fundamentals.

GENK Fundamentals

MetricStatus
Stable
Weak
Under pressure
Strong

GENK's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.

NKE Fundamentals

MetricStatus
Stable
Healthy
Stable
Strong

NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.

GENK PE Valuation

GENK has no meaningful PE right now: it lost money over the past year.

NKE PE Valuation

CHEAPFAIREXPENSIVE21x43x64x86x
CHEAPFAIREXPENSIVE21x43x64x86x
LevelPEPriceVs current
Current18x$37.76—
Cheap23x$47.70+26%
Forward30x$37.76—
Fair33x$68.16+80%
Expensive47x$97.86+159%

Historical ranges are pointers, not guarantees.

NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.

GENK Forward outlook

MetricOutlook
--
Losses shrinking
Stable
Stable
Limited
High

Analysts expect GENK's losses to shrink, with revenue holding steady.

NKE Forward outlook

MetricOutlook
Strongly deteriorating
Stable
Decline
Improving
Moderate
Low

Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.

GENK Risk to reward

ScenarioChangePrice
Upside+56%$1.50
Downside-35%$0.62

Calculated from the latest close: $0.96 on Nov 12.

GENK has a better modeled risk to reward balance than NKE, with more potential upside relative to its potential downside.

NKE Risk to reward

ScenarioChangePrice
Upside+25%$47.36
Downside-18%$30.83

Calculated from the latest close: $37.76 on Nov 12.

NKE trails GENK on modeled risk to reward, with less potential upside relative to its potential downside.

GENK Earnings Per Share

Q4 2023: $2.01Q1 2024: $1.12Q2 2024: $0.24Q3 2024: $0.17Q4 2024: $0.13Q1 2025: $-0.04Q2 2025: $-0.15Q3 2025: $-0.27Q4 2025: $-0.59Q1 2026: $-0.75Q2 2026: $-0.84Q3 2026: $-0.89
Q4 2023: $2.01Q1 2024: $1.12Q2 2024: $0.24Q3 2024: $0.17Q4 2024: $0.13Q1 2025: $-0.04Q2 2025: $-0.15Q3 2025: $-0.27Q4 2025: $-0.59Q1 2026: $-0.75Q2 2026: $-0.84Q3 2026: $-0.89
QuarterTTM EPSYoY
Q3 2026-$0.89-$0.62
Q2 2026-$0.84-$0.69
Q1 2026-$0.75-$0.71
Q4 2025-$0.59-554%
Q3 2025-$0.27-259%
Q2 2025-$0.15-163%
Q1 2025-$0.04-104%
Q4 2024$0.13-94%

GENK lost $0.89 per share over the past year, and its loss has widened in each of the last 11 quarters.

NKE Earnings Per Share

Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
QuarterTTM EPSYoY
Forward$1.27-39%
Q3 2026$2.09+7.2%
Q2 2026$2.10-2.8%
Q1 2026$1.51-50%
Q4 2025$1.70-48%
Q3 2025$1.95-44%
Q2 2025$2.16-42%
Q1 2025$3.01-11%
Q4 2024$3.24-5.3%

NKE has the edge over GENK on earnings quality, reporting a profit while its opponent remains loss making.

GENK Quarterly Revenue

Q4 2023: $45MQ1 2024: $51MQ2 2024: $54MQ3 2024: $49MQ4 2024: $55MQ1 2025: $57MQ2 2025: $55MQ3 2025: $50MQ4 2025: $50MQ1 2026: $54MQ2 2026: $56MQ3 2026: $49M
Q4 2023: $45MQ1 2024: $51MQ2 2024: $54MQ3 2024: $49MQ4 2024: $55MQ1 2025: $57MQ2 2025: $55MQ3 2025: $50MQ4 2025: $50MQ1 2026: $54MQ2 2026: $56MQ3 2026: $49M
QuarterRevenueYoY
Q3 2026$48.7M-3.3%
Q2 2026$55.7M+1.2%
Q1 2026$53.9M-6%
Q4 2025$49.7M-9%
Q3 2025$50.4M+2.7%
Q2 2025$55M+2.2%
Q1 2025$57.3M+13%
Q4 2024$54.7M+21%

GENK has the edge over NKE on sales, with more consistent year-over-year improvement.

NKE Quarterly Revenue

Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
QuarterRevenueYoY
Q3 2026$11.2B-4.3%
Q2 2026$11B-1.1%
Q1 2026$11.3B+0.1%
Q4 2025$12.4B+0.6%
Q3 2025$11.7B+1.1%
Q2 2025$11.1B-12%
Q1 2025$11.3B-9.3%
Q4 2024$12.4B-7.7%

NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.

GENK Free Cash Flow

Q4 2023: $983,000Q1 2024: −$586,000Q2 2024: $1MQ3 2024: −$7MQ4 2024: $165,000Q1 2025: −$5MQ2 2025: −$6MQ3 2025: −$8MQ4 2025: −$6MQ1 2026: −$667,000Q2 2026: −$5MQ3 2026: −$7M
Q4 2023: $983,000Q1 2024: −$586,000Q2 2024: $1MQ3 2024: −$7MQ4 2024: $165,000Q1 2025: −$5MQ2 2025: −$6MQ3 2025: −$8MQ4 2025: −$6MQ1 2026: −$667,000Q2 2026: −$5MQ3 2026: −$7M
QuarterFree cash flowYoY
Q3 2026-$6.9M+$767K
Q2 2026-$5.5M+$835K
Q1 2026-$667K+$4M
Q4 2025-$5.6M-3516%
Q3 2025-$7.7M-$870K
Q2 2025-$6.3M-605%
Q1 2025-$4.7M-$4.1M
Q4 2024$165K-83%

GENK has burned cash in most quarters: −$19M over the past year, against −$19M the year before.

NKE Free Cash Flow

Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
QuarterFree cash flowYoY
Q3 2026-$64M-527%
Q2 2026$1.5B+313%
Q1 2026$284M-83%
Q4 2025$386M-58%
Q3 2025$15M-95%
Q2 2025$363M-85%
Q1 2025$1.7B-11%
Q4 2024$920M-65%

NKE has the edge over GENK on cash generation, producing positive trailing cash flow while its opponent burns cash.

GENK Total Shares

Q4 2023: 4MQ1 2024: 4MQ2 2024: 5MQ3 2024: 5MQ4 2024: 5MQ1 2025: 5MQ2 2025: 5MQ3 2025: 5MQ4 2025: 5MQ1 2026: 5MQ2 2026: 5MQ3 2026: 6M
Q4 2023: 4MQ1 2024: 4MQ2 2024: 5MQ3 2024: 5MQ4 2024: 5MQ1 2025: 5MQ2 2025: 5MQ3 2025: 5MQ4 2025: 5MQ1 2026: 5MQ2 2026: 5MQ3 2026: 6M
PeriodChange %Net change
Quarterly+17%+935K shares
1 year+20%+1.1M shares
3 years+52%+2.2M shares
5 years+75%+2.7M shares

GENK has 6M diluted shares, up 20% from a year ago.

NKE Total Shares

Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
PeriodChange %Net change
Quarterly+0.2%+3.2M shares
1 year+0.4%+5.2M shares
3 years-3.8%-59.1M shares
5 years-8.4%-135M shares
Available history-6.9%-110M shares

NKE has the edge over GENK on shareholder dilution, with a more favorable share count trend.

GENK Net Leverage

Q4 2023: -1.8xQ1 2024: -2.0xQ2 2024: -2.4xQ3 2024: -2.1xQ4 2024: -2.3xQ1 2025: -1.6xQ2 2025: -0.7x
Q4 2023: -1.8xQ1 2024: -2.0xQ2 2024: -2.4xQ3 2024: -2.1xQ4 2024: -2.3xQ1 2025: -1.6xQ2 2025: -0.7x
QuarterNet LeverageStatus
Q2 2025-0.7xNet Cash
Q1 2025-1.6xNet Cash
Q4 2024-2.3xNet Cash
Q3 2024-2.1xNet Cash
Q2 2024-2.4xNet Cash
Q1 2024-2.0xNet Cash
Q4 2023-1.8xNet Cash
Q3 2023-1.6xNet Cash

GENK has more cash than debt.

NKE Net Leverage

Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
QuarterNet LeverageStatus
Q3 20260.2xVery low
Q2 20260.1xVery low
Q1 20250.1xVery low
Q4 20240.2xVery low
Q3 20240.1xVery low
Q2 2024-0.1xNet Cash
Q1 2024-0.0xVery low
Q4 20230.1xVery low

NKE's net debt is less than a year of its operating earnings (EBITDA).

GENK Weekly Momentum

MetricValueStatus
RSI25.8Oversold
Stochastic5.4Oversold

GENK's weekly RSI is 26 (oversold) and its Stochastic is 5 (oversold).

NKE Weekly Momentum

MetricValueStatus
RSI40.0Neutral
Stochastic57.5Neutral

NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).

GENK PE vs Consumer Cyclical Sector

MetricGENKSector medianRelative
PEN/A18x—

GENK has no meaningful PE right now: it lost money over the past year.

NKE PE vs Consumer Cyclical Sector

MetricNKESector medianRelative
PE18x18x0.3% above
PE %24745 pts below

NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.

GENK Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.4936% below
20 week MA$1.7545% below
50 week MA$1.9150% below
100 week MA$3.1770% below

NKE has stronger trend alignment. GENK is above 0 of 4 weekly averages versus NKE above 1 of 5.

NKE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$36.72.8% above
20 week MA$39.23.6% below
50 week MA$48.021% below
100 week MA$58.435% below
200 week MA$79.252% below

NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.

GENK Yearly ROI

YearStart priceEnd priceROI
2023$17.0$7.83-54%
2024$7.83$7.40-5.5%
2025$7.40$2.41-67%
2026 YTD$2.41$0.96-60%

GENK has finished every year since 2023 lower, and it's down 60% so far in 2026.

NKE Yearly ROI

YearStart priceEnd priceROI
2020$101.6$141.6+39%
2021$141.6$165.7+17%
2022$165.7$116.3-30%
2023$116.3$108.6-6.6%
2024$108.6$76.4-30%
2025$76.4$60.9-20%
2026 YTD$60.9$37.8-38%

NKE has the edge over GENK on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key